University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Publications for Norris Cancer Center Members in the Hematologic and Viral-Associated Malignancies Program

  • If you want to only view publications for one year, enter the 4 digit Year (e.g., 2001) and click Filter.
  • Authors who are Program members appear in bold.
  • Authors who are CC members from other programs are underlined.

Filter by Publication Year:From: To:

Total Number of Publications: 415
Inter Programmatic Publications: 112
Intra Programmatic Publications: 65

1: Estécio MR, Gharibyan V, Shen LJ, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP
LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability.
PLoS One 2: e399 (2007)
PM ID: 17476321 PMC1851990
2: Kaur P, Feldhahn N, Zhang B, Trageser D, Müschen M, Pertz V, Groffen J, Heisterkamp N
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia.
Mol Cancer 6: 67 (2007)
PM ID: 17958915 PMC2169263
3: Tsou JA, Galler JS, Siegmund KD, Laird PW, Turla S, Cozen W, Hagen JA, Koss MN, Laird-Offringa IA
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.
Mol Cancer 6: 70 (2007)
PM ID: 17967182 PMC2206053
4: Lu H, Schwarz K, Lieber MR
Extent to which hairpin opening by the Artemis:DNA-PKcs complex can contribute to junctional diversity in V(D)J recombination.
Nucleic Acids Res 35: 6917-23 (2007)
PM ID: 17932067 PMC2175297
5: Gu J, Lu H, Tsai AG, Schwarz K, Lieber MR
Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: influence of terminal DNA sequence.
Nucleic Acids Res 35: 5755-62 (2007)
PM ID: 17717001 PMC2034460
6: Chu MW, Siegmund KD, Eckstam CL, Kim JY, Yang AS, Kanel GC, Tavaré S, Shibata D
Lack of increases in methylation at three CpG-rich genomic loci in non-mitotic adult tissues during aging.
BMC Med Genet 8: 50 (2007)
PM ID: 17672908 PMC1950491
7: Raghavan SC, Lieber MR
DNA structure and human diseases.
Front Biosci 12: 4402-8 (2007)
PM ID: 17485384
8: Flanagan ML, Arias RS, Hu P, Khawli LA, Epstein AL
Soluble Fc fusion proteins for biomedical research.
Methods Mol Biol 378: 33-52 (2007)
PM ID: 18605076
9: Mishra S, Pertz V, Zhang B, Kaur P, Shimada H, Groffen J, Kazimierczuk Z, Pinna LA, Heisterkamp N
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2.
Leukemia 21: 178-80 (2007)
PM ID: 17082777
10: Kohn DB
Lentiviral vectors ready for prime-time.
Nat Biotechnol 25: 65-6 (2007)
PM ID: 17211402
11: Blumenthal M, Skelton DC, Pepper KA, Jahn T, Methangkool E, Kohn DB
Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice.
Mol Ther 15: 183-92 (2007)
PM ID: 17164790
12: Bahner I, Sumiyoshi T, Kagoda M, Swartout R, Peterson D, Pepper K, Dorey F, Reiser J, Kohn DB
Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
Mol Ther 15: 76-85 (2007)
PM ID: 17164778
13: Engel BC, Podsakoff GM, Ireland JL, Smogorzewska EM, Carbonaro DA, Wilson K, Shah AJ, Kapoor N, Sweeney M, Borchert M, Crooks GM, Weinberg KI, Parkman R, Rosenblatt HM, Wu SQ, Hershfield MS, Candotti F, Kohn DB
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.
Blood 109: 503-6 (2007)
PM ID: 16973956 PMC1785101
14: Fischer-Lougheed JY, Tarantal AF, Shulkin I, Mitsuhashi N, Kohn DB, Lee CC, Kearns-Jonker M
Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates.
Gene Ther 14: 49-57 (2007)
PM ID: 16886002
15: Cho YJ, Cunnick JM, Yi SJ, Kaartinen V, Groffen J, Heisterkamp N
Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages.
Mol Cell Biol 27: 899-911 (2007)
PM ID: 17116687 PMC1800684
16: Lim ST, Fayad L, Tulpule A, Modiano M, Cabanillas F, Laffranchi B, Allievi C, Bernareggi A, Levine AM
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.
Leuk Lymphoma 48: 374-80 (2007)
PM ID: 17325899
17: Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang JK, Marinelli B, Pesatori AC, Bertazzi PA, Yang AS
Changes in DNA methylation patterns in subjects exposed to low-dose benzene.
Cancer Res 67: 876-80 (2007)
PM ID: 17283117
18: Gu J, Lu H, Tippin B, Shimazaki N, Goodman MF, Lieber MR
XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps.
EMBO J 26: 1010-23 (2007)
PM ID: 17290226 PMC1852838
19: Boffetta P, Armstrong B, Linet MS, Kasten C, Cozen W, Hartge P
Consortia in cancer epidemiology: lessons from InterLymph.
Cancer Epidemiol Biomarkers Prev 16: 197-9 (2007)
PM ID: 17301250
20: Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz MJ, Carroll AJ, Heerema NA, Rubnitz JE, Loh ML, Raetz EA, Winick NJ, Hunger SP, Carroll WL, Gaynon PS, Camitta BM
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood 109: 926-35 (2007)
PM ID: 17003380 PMC1785141
21: Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM, Kronenberg HM, Scadden DT
Therapeutic targeting of a stem cell niche.
Nat Biotechnol 25: 238-43 (2007)
PM ID: 17237769
22: Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL
Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers.
Minerva Gastroenterol Dietol 53: 1-7 (2007)
PM ID: 17415341
23: Grulich AE, Vajdic CM, Cozen W
Altered immunity as a risk factor for non-Hodgkin lymphoma.
Cancer Epidemiol Biomarkers Prev 16: 405-8 (2007)
PM ID: 17337643
24: Meixlsperger S, Köhler F, Wossning T, Reppel M, Müschen M, Jumaa H
Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor.
Immunity 26: 323-33 (2007)
PM ID: 17331747
25: Wang SS, Slager SL, Brennan P, Holly EA, de Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, Mensah F, Zhang Y, Nieters A, Dal Maso L, Bracci PM, Costantini AS, Vineis P, Severson RK, Roman E, Cozen W, Weisenburger DD, Davis S, Franceschi S, La Vecchia C, Foretova L, Becker N, Staines A, Vornanen M, Zheng T, Hartge P
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).
Blood 109: 3479-88 (2007)
PM ID: 17185468 PMC1852242
26: Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.
Br J Cancer 96: 1083-91 (2007)
PM ID: 17353927 PMC2360128
27: Damschroder MM, Widjaja L, Gill PS, Krasnoperov V, Jiang W, Dall'Acqua WF, Wu H
Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties.
Mol Immunol 44: 3049-60 (2007)
PM ID: 17241664
28: Ku TK, Nguyen DC, Karaman MW, Gill P, Hacia JG, Crowe DL
Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Mol Cancer Res 5: 351-62 (2007)
PM ID: 17426250
29: Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock SJ, Davis S, Blair A, Schenk M, Rothman N, Lan Q
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
Blood 109: 3050-9 (2007)
PM ID: 17119116 PMC1852210
30: Lu H, Pannicke U, Schwarz K, Lieber MR
Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity.
J Biol Chem 282: 11155-62 (2007)
PM ID: 17317666
31: Douer D, Yampolsky H, Cohen LJ, Watkins K, Levine AM, Periclou AP, Avramis VI
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
Blood 109: 2744-50 (2007)
PM ID: 17132721
32: Kondo Y, Sung VM, Machida K, Liu M, Lai MM
Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines.
Virology 361: 161-73 (2007)
PM ID: 17175001
33: Zhu NL, Li C, Huang HH, Sebald M, Londhe VA, Heisterkamp N, Warburton D, Bellusci S, Minoo P
TNF-alpha represses transcription of human Bone Morphogenetic Protein-4 in lung epithelial cells.
Gene 393: 70-80 (2007)
PM ID: 17350185 PMC1945170 NIHMS22407
34: Shah AJ, Kapoor N, Crooks GM, Weinberg KI, Azim HA, Killen R, Kuo L, Rushing T, Kohn DB, Parkman R
The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants.
Biol Blood Marrow Transplant 13: 584-93 (2007)
PM ID: 17448918
35: Rountree CB, Wang XD, Ge S, Barsky LW, Zhu JY, Gonzales I, Crooks GM
Bone marrow fails to differentiate into liver epithelium during murine development and regeneration.
Hepatology 45: 1250-60 (2007)
PM ID: 17464997
36: Garon EB, Marcu L, Luong Q, Tcherniantchouk O, Crooks GM, Koeffler HP
Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells.
Leuk Res 31: 643-51 (2007)
PM ID: 17027955
37: Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, Franklin J, Siegel SE, Seibel NL, Rogers PC, Sather H, Trigg M, Bleyer WA, Carroll WL
Obesity and outcome in pediatric acute lymphoblastic leukemia.
J Clin Oncol 25: 2063-9 (2007)
PM ID: 17513811
38: López-Gatell H, Cole SR, Hessol NA, French AL, Greenblatt RM, Landesman S, Preston-Martin S, Anastos K
Effect of tuberculosis on the survival of women infected with human immunodeficiency virus.
Am J Epidemiol 165: 1134-42 (2007)
PM ID: 17339383
39: Zhang N, Sadun RE, Arias RS, Flanagan ML, Sachsman SM, Nien YC, Khawli LA, Hu P, Epstein AL
Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors.
Clin Cancer Res 13: 2758-67 (2007)
PM ID: 17460060
40: Colt JS, Hartge P, Davis S, Cerhan JR, Cozen W, Severson RK
Hobbies with solvent exposure and risk of non-Hodgkin lymphoma.
Cancer Causes Control 18: 385-90 (2007)
PM ID: 17262168
41: Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P
Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Cancer Res 67: 5042-54 (2007)
PM ID: 17510437
42: Tobin E, Denardo G, Zhang N, Epstein AL, Liu C, Denardo S
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines.
Leuk Lymphoma 48: 944-56 (2007)
PM ID: 17487739
43: Pullarkat V, Veliz L, Chang KJ, Mohrbacher AF, Teotico AL, Forman SJ, Slovak ML
Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus.
J Clin Pathol 60: 562-4 (2007)
PM ID: 17513515
44: Islam T, Gauderman WJ, Cozen W, Mack TM
Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins.
Neurology 69: 381-8 (2007)
PM ID: 17646631
45: Feldhahn N, Henke N, Melchior K, Duy C, Soh BN, Klein F, von Levetzow G, Giebel B, Li AX, Hofmann WK, Jumaa H, Müschen M
Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
J Exp Med 204: 1157-66 (2007)
PM ID: 17485517 PMC2118573
46: Zhang B, Groffen J, Heisterkamp N
Increased resistance to a farnesyltransferase inhibitor by N-cadherin expression in Bcr/Abl-P190 lymphoblastic leukemia cells.
Leukemia 21: 1189-97 (2007)
PM ID: 17392819
47: Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
Blood 109: 5439-46 (2007)
PM ID: 17327408 PMC1890834
48: Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS
Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion.
Blood 109: 4753-60 (2007)
PM ID: 17311993 PMC1885521
49: Arias RS, Flanagan ML, Miller KD, Nien YC, Hu P, Gray D, Khawli LA, Epstein AL
RA8, a human anti-CD25 antibody against human Treg cells.
Hybridoma (Larchmt) 26: 119-30 (2007)
PM ID: 17600493
50: Zhang N, Khawli LA, Hu P, Epstein AL
Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors.
Cancer Biother Radiopharm 22: 342-56 (2007)
PM ID: 17651040
51: Raghavan SC, Gu J, Swanson PC, Lieber MR
The structure-specific nicking of small heteroduplexes by the RAG complex: implications for lymphoid chromosomal translocations.
DNA Repair (Amst) 6: 751-9 (2007)
PM ID: 17307402 PMC2692700 NIHMS25228
52: Tarantino MD, Bussel JB, Cines DB, McCrae KR, Gernsheimer T, Liebman HA, Wong WY, Kulkarni R, Grabowski E, McMillan R
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).
Blood 109: 5527; author reply 5528 (2007)
PM ID: 17554071
53: Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).
Blood 110: 695-708 (2007)
PM ID: 17389762 PMC1924473
54: Sadun RE, Sachsman SM, Chen X, Christenson KW, Morris WZ, Hu P, Epstein AL
Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.
Clin Cancer Res 13: 4016-25 (2007)
PM ID: 17606736
55: Heerema NA, Raimondi SC, Anderson JR, Biegel JA, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, McGavran L, Patil S, Pettenati MJ, Pullen J, Rao KV, Roulston D, Schneider NR, Shuster JJ, Sanger WG, Sutcliffe MJ, van Tuinen P, Watson MS, Carroll AJ
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.
Genes Chromosomes Cancer 46: 684-93 (2007)
PM ID: 17431878
56: Qin T, Youssef EM, Jelinek J, Chen RL, Yang AS, Garcia-Manero G, Issa JP
Effect of cytarabine and decitabine in combination in human leukemic cell lines.
Clin Cancer Res 13: 4225-32 (2007)
PM ID: 17634552
57: Huang FT, Yu KJ, Balter BB, Selsing E, Oruc Z, Khamlichi AA, Hsieh CL, Lieber MR
Sequence dependence of chromosomal R-loops at the immunoglobulin heavy-chain Smu class switch region.
Mol Cell Biol 27: 5921-32 (2007)
PM ID: 17562862 PMC1952116
58: Ding W, Shi W, Bellusci S, Groffen J, Heisterkamp N, Minoo P, Warburton D
Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
J Cell Physiol 212: 796-806 (2007)
PM ID: 17516543
59: Higashimoto T, Urbinati F, Perumbeti A, Jiang G, Zarzuela A, Chang LJ, Kohn DB, Malik P
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
Gene Ther 14: 1298-304 (2007)
PM ID: 17597793
60: Choi SH, Byun HM, Kwan JM, Issa JP, Yang AS
Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition.
Br J Haematol 138: 616-23 (2007)
PM ID: 17686055
61: Liebman HA, Stasi R
Secondary immune thrombocytopenic purpura.
Curr Opin Hematol 14: 557-73 (2007)
PM ID: 17934365
62: Cozen W, Cerhan JR, Martinez-Maza O, Ward MH, Linet MS, Colt JS, Davis S, Severson RK, Hartge P, Bernstein L
The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.
Cancer Causes Control 18: 821-31 (2007)
PM ID: 17588155
63: Berg T, Rountree CB, Lee L, Estrada J, Sala FG, Choe A, Veltmaat JM, De Langhe S, Lee RH, Tsukamoto H, Crooks GM, Bellusci S, Wang KS
Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation.
Hepatology 46: 1187-97 (2007)
PM ID: 17668871
64: Rountree CB, Barsky LW, Ge S, Zhu JY, Senadheera S, Crooks GM
A CD133-expressing murine liver oval cell population with bilineage potential.
Stem Cells 25: 2419-29 (2007)
PM ID: 17585168
65: Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK, Rogerio JW, Triche TJ, He Q, Wu L
Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells.
Stem Cells 25: 2628-37 (2007)
PM ID: 17628022
66: Liebman H
Other immune thrombocytopenias.
Semin Hematol 44: S24-34 (2007)
PM ID: 18096469
67: Weitz IC, Liebman HA
The role of oral anticoagulants in tumor biology.
Semin Thromb Hemost 33: 695-8 (2007)
PM ID: 18000797
68: Rodriguez RT, Velkey JM, Lutzko C, Seerke R, Kohn DB, O'Shea KS, Firpo MT
Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types.
Exp Biol Med (Maywood) 232: 1368-80 (2007)
PM ID: 17959850
69: Purdue MP, Hartge P, Davis S, Cerhan JR, Colt JS, Cozen W, Severson RK, Li YT, Chanock SJ, Rothman N, Wang SS
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma.
Cancer Causes Control 18: 989-99 (2007)
PM ID: 17653830
70: Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS
Examination of IGF2 and H19 loss of imprinting in bladder cancer.
Cancer Res 67: 10753-8 (2007)
PM ID: 18006818
71: Rossi JJ, June CH, Kohn DB
Genetic therapies against HIV.
Nat Biotechnol 25: 1444-54 (2007)
PM ID: 18066041
72: Malempati S, Gaynon PS, Sather H, La MK, Stork LC, Children's Oncology Group
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
J Clin Oncol 25: 5800-7 (2007)
PM ID: 18089878
73: Ask K, Bonniaud P, Maass K, Eickelberg O, Margetts PJ, Warburton D, Groffen J, Gauldie J, Kolb M
Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3.
Int J Biochem Cell Biol 40: 484-95 (2008)
PM ID: 17931953 PMC2350199 NIHMS42236
74: Khawli LA, Hu P, Epstein AL
Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Handb Exp Pharmacol : 291-328 (2008)
PM ID: 18071951
75: Basile LA, Gallaher TK, Shibata D, Miller JD, Douer D
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice.
J Transl Med 6: 26 (2008)
PM ID: 18489769 PMC2424034
76: Wang SS, Davis S, Hartge P, Cozen W, Severson RK, Cerhan JR, Rothman N
Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma.
J Natl Cancer Inst Monogr : 78-82 (2008)
PM ID: 18648009
77: Benedito R, Trindade A, Hirashima M, Henrique D, da Costa LL, Rossant J, Gill PS, Duarte A
Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli.
BMC Dev Biol 8: 117 (2008)
PM ID: 19087347 PMC2637862
78: Lieber MR, Raghavan SC, Yu KJ
Mechanistic aspects of lymphoid chromosomal translocations.
J Natl Cancer Inst Monogr : 8-11 (2008)
PM ID: 18647994
79: Liebman HA
Viral-associated immune thrombocytopenic purpura.
Hematology Am Soc Hematol Educ Program : 212-8 (2008)
PM ID: 19074085
80: Liebman HA
Immune thrombocytopenia (ITP): an historical perspective.
Hematology Am Soc Hematol Educ Program : 205 (2008)
PM ID: 19074083
81: Kohn DB
Gene therapy for childhood immunological diseases.
Bone Marrow Transplant 41: 199-205 (2008)
PM ID: 17994122
82: Taylor JA, Vojtech L, Bahner I, Kohn DB, Laer DV, Russell DW, Richard RE
Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Mol Ther 16: 46-51 (2008)
PM ID: 17955023
83: Lieber MR
The mechanism of human nonhomologous DNA end joining.
J Biol Chem 283: 1-5 (2008)
PM ID: 17999957
84: Roy D, Yu KJ, Lieber MR
Mechanism of R-loop formation at immunoglobulin class switch sequences.
Mol Cell Biol 28: 50-60 (2008)
PM ID: 17954560 PMC2223306
85: Minoo P, Hu L, Zhu NL, Borok Z, Bellusci S, Groffen J, Kardassis D, Li C
SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains.
Nucleic Acids Res 36: 179-88 (2008)
PM ID: 18003659 PMC2248754
86: Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL
Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.
Clin Cancer Res 14: 579-88 (2008)
PM ID: 18223234
87: Bonde J, Wirthlin L, Kohn DB, Nolta JA
Human hematopoietic cell culture, transduction, and analyses.
Curr Protoc Hum Genet Chapter 13: Unit 13.7 (2008)
PM ID: 18428422
88: Maskarinec G, Erber E, Gill JK, Cozen W, Kolonel LN
Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort.
Cancer Epidemiol Biomarkers Prev 17: 196-203 (2008)
PM ID: 18187389
89: Anderson LA, Gridley G, Engels EA, Morton LM, Cerhan JR, Cozen W, Severson RK, Davis S, Hartge P, Linet MS
Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study.
Br J Cancer 98: 161-4 (2008)
PM ID: 18059393 PMC2359683
90: Lieber MR, Lu H, Gu J, Schwarz K
Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system.
Cell Res 18: 125-33 (2008)
PM ID: 18087292
91: Lai CK, Jeng KS, Machida K, Cheng YS, Lai MM
Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation.
Virology 370: 295-309 (2008)
PM ID: 17931678
92: Shen M, Cozen W, Huang LM, Colt JS, De Roos AJ, Severson RK, Cerhan JR, Bernstein L, Morton LM, Pickle L, Ward MH
Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma.
Am J Epidemiol 167: 350-61 (2008)
PM ID: 17989060
93: Hao QL, George AA, Zhu JY, Barsky LW, Zielinska E, Wang XD, Price MA, Ge S, Crooks GM
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors.
Blood 111: 1318-26 (2008)
PM ID: 17959857 PMC2214748
94: Kweon SM, Cho YJ, Minoo P, Groffen J, Heisterkamp N
Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor.
J Biol Chem 283: 3023-30 (2008)
PM ID: 18070886
95: Dowd CL, Sutch BT, Haworth IS, Eritja R, Marquez VE, Yang AS
Incorporation of zebularine from its 2'-deoxyribonucleoside triphosphate derivative and activity as a template-coding nucleobase.
Nucleosides Nucleotides Nucleic Acids 27: 131-45 (2008)
PM ID: 18205068
96: Gu J, Lieber MR
Mechanistic flexibility as a conserved theme across 3 billion years of nonhomologous DNA end-joining.
Genes Dev 22: 411-5 (2008)
PM ID: 18281457 PMC2731650
97: Tsai AG, Lieber MR
RAGs found "not guilty": cleared by DNA evidence.
Blood 111: 1750 (2008)
PM ID: 19048671
98: Shimazaki N, Lieber MR
DNA-PKcs at 7 angstrom: insights for DNA repair.
Structure 16: 334-6 (2008)
PM ID: 18334206
99: Song XT, Evel-Kabler K, Shen L, Rollins L, Huang XF, Chen SY
A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression.
Nat Med 14: 258-65 (2008)
PM ID: 18311150
100: Abdel-Azim H, Zhu Y, Hollis RP, Wang XD, Ge S, Hao QL, Smbatyan G, Kohn DB, Rosol M, Crooks GM
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl.
Blood 111: 4064-74 (2008)
PM ID: 18174381 PMC2288719
101: Rountree CB, Senadheera S, Mato JM, Crooks GM, Lu SC
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice.
Hepatology 47: 1288-97 (2008)
PM ID: 18167064 PMC2408692 NIHMS49822
102: Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H, Hackett PB, Kohn DB, Shpall EJ, Champlin RE, Cooper LJ
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.
Cancer Res 68: 2961-71 (2008)
PM ID: 18413766 PMC2424272 NIHMS52003
103: Lee YC, Morgenstern H, Greenland S, Tashkin DP, Papp J, Sinsheimer J, Cao W, Hashibe M, You NC, Mao JT, Cozen W, Mack TM, Zhang ZF
A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers.
Int J Cancer 122: 1630-8 (2008)
PM ID: 18059021 PMC2676936 NIHMS96130
104: Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG, Gauderman WJ, Martínez-Maza O, Nathwani BN, Pike MC, Van Den Berg DJ, Hamilton AS, Deapen DM, Mack TM
Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma.
Blood 111: 3377-82 (2008)
PM ID: 18077789 PMC2275007
105: Cozen W, Avol E, Diaz-Sanchez D, McConnell R, Gauderman WJ, Cockburn MG, Zadnick J, Jyrala M, Mack TM
Use of an electrostatic dust cloth for self-administered home allergen collection.
Twin Res Hum Genet 11: 150-5 (2008)
PM ID: 18361715
106: Feng L, Barnhart JR, Seeger RC, Wu L, Keshelava N, Huang SH, Jong A
Cdc6 knockdown inhibits human neuroblastoma cell proliferation.
Mol Cell Biochem 311: 189-97 (2008)
PM ID: 18259842
107: Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner JS, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett EV, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco PL, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson RK, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Blood 111: 4029-38 (2008)
PM ID: 18263783 PMC2288717
108: de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadié M, Cocco PL, Bosch R, Foretova L, Staines A, Becker N, Nieters A
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
Clin Gastroenterol Hepatol 6: 451-8 (2008)
PM ID: 18387498
109: Heo K, Kim HJ, Choi SH, Choi J, Kim KJ, Gu J, Lieber MR, Yang AS, An W
FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16.
Mol Cell 30: 86-97 (2008)
PM ID: 18406329
110: Sadun RE, Hsu WE, Zhang N, Nien YC, Bergfeld SA, Sabzevari H, Lutsiak ME, Khawli L, Hu P, Epstein AL
Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor models.
J Immunother 31: 235-45 (2008)
PM ID: 18317364
111: Karantza MV, Mittelman SD, Dorey F, Samie S, Kaiserman K, Halvorson M, Kaufman FR
Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus.
Pediatr Diabetes 9: 122-6 (2008)
PM ID: 18036131
112: Heisterkamp N, Groffen J, Warburton D, Sneddon TP
The human gamma-glutamyltransferase gene family.
Hum Genet 123: 321-32 (2008)
PM ID: 18357469
113: Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, Cai L, Cozen W, Mack TM, Lu QY, Zhang ZF
Dietary flavonoid intake and lung cancer--a population-based case-control study.
Cancer 112: 2241-8 (2008)
PM ID: 18327817
114: Frankenfeld CL, Cerhan JR, Cozen W, Davis S, Schenk M, Morton LM, Hartge P, Ward MH
Dietary flavonoid intake and non-Hodgkin lymphoma risk.
Am J Clin Nutr 87: 1439-45 (2008)
PM ID: 18469269
115: Wang H, Cao C, Li B, Chen SP, Yin J, Shi J, Ye D, Tao Q, Hu P, Epstein AL, Ju DW
Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients.
Cancer Immunol Immunother 57: 677-84 (2008)
PM ID: 17934732
116: Carbonaro DA, Jin X, Cotoi D, Mi T, Yu XJ, Skelton DC, Dorey F, Kellems RE, Blackburn MR, Kohn DB
Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
Blood 111: 5745-54 (2008)
PM ID: 18356486 PMC2424166
117: Kelemen LE, Wang SS, Lim U, Cozen W, Schenk M, Hartge P, Li YT, Rothman N, Davis S, Chanock SJ, Ward MH, Cerhan JR
Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk.
Cancer Causes Control 19: 491-503 (2008)
PM ID: 18204928
118: Chu MW, Siegmund KD, Hao QL, Crooks GM, Tavaré S, Shibata D
Inferring relative numbers of human leucocyte genome replications.
Br J Haematol 141: 862-71 (2008)
PM ID: 18410448
119: Shah AJ, Epport K, Azen CG, Killen R, Wilson K, De Clerck D, Crooks GM, Kapoor N, Kohn DB, Parkman R, Weinberg KI
Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies.
J Pediatr Hematol Oncol 30: 411-8 (2008)
PM ID: 18525456
120: Trigg ME, Sather HN, Reaman GH, Tubergen DG, Steinherz PG, Gaynon PS, Uckun FM, Hammond GD, Children's Oncology Group
Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Leuk Lymphoma 49: 1142-54 (2008)
PM ID: 18569638
121: Di Iorgi N, Rosol M, Mittelman SD, Gilsanz V
Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults.
J Clin Endocrinol Metab 93: 2281-6 (2008)
PM ID: 18381577 PMC2435643
122: Dolev JC, Maurer T, Springer G, Glesby MJ, Minkoff H, Connell C, Young M, Schowalter K, Cox C, Hessol NA
Incidence and risk factors for verrucae in women.
AIDS 22: 1213-9 (2008)
PM ID: 18525267 PMC2615554 NIHMS84729
123: Melchior K, Weiss JM, Zaehres H, Kim YM, Lutzko C, Roosta N, Hescheler J, Müschen M
The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells.
Biol Chem 389: 897-903 (2008)
PM ID: 18681827
124: Müschen M
Highlight: self-renewal signaling in stem cells.
Biol Chem 389: 787 (2008)
PM ID: 18681824
125: Robinson KS, Williams ME, van der Jagt RH, Cohen P, Herst JA, Tulpule A, Schwartzberg LS, Lemieux B, Cheson BD
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
J Clin Oncol 26: 4473-9 (2008)
PM ID: 18626004
126: Liang C, Lee JS, Inn KS, Gack MU, Li Q, Roberts EA, Vergne I, Deretic V, Feng P, Akazawa C, Jung JU
Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking.
Nat Cell Biol 10: 776-87 (2008)
PM ID: 18552835
127: Machida K, Kondo Y, Huang JY, Chen YC, Cheng KT, Keck Z, Foung S, Dubuisson J, Sung VM, Lai MM
Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
J Virol 82: 6711-20 (2008)
PM ID: 18417597 PMC2447061
128: Kahl CA, Cannon PM, Oldenburg J, Tarantal AF, Kohn DB
Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
Gene Ther 15: 1079-89 (2008)
PM ID: 18385767
129: Alexy T, Tucker S, Boyle S, Rowe VL, Weaver FA, Liebman HA
Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
J Vasc Surg 48: 377-81 (2008)
PM ID: 18515040
130: Cerhan JR, Engels EA, Cozen W, Davis S, Severson RK, Morton LM, Gridley G, Hartge P, Linet MS
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
Int J Cancer 123: 888-94 (2008)
PM ID: 18506687
131: Byun HM, Choi SH, Laird PW, Trinh BN, Siddiqui MA, Marquez VE, Yang AS
2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1.
Cancer Lett 266: 238-48 (2008)
PM ID: 18499340 PMC2528876 NIHMS57985
132: Lu H, Shimazaki N, Raval P, Gu J, Watanabe G, Schwarz K, Swanson PC, Lieber MR
A biochemically defined system for coding joint formation in V(D)J recombination.
Mol Cell 31: 485-97 (2008)
PM ID: 18722175 PMC2564285 NIHMS67395
133: Raetz EA, Borowitz MJ, Devidas M, Linda SB, Hunger SP, Winick NJ, Camitta BM, Gaynon PS, Carroll WL
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
J Clin Oncol 26: 3971-8 (2008)
PM ID: 18711187 PMC2654313
134: Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI, Triche TJ, Shimada H, Anderson MJ
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Cancer Res 68: 6587-97 (2008)
PM ID: 18701482
135: Larsson J, Ohishi M, Garrison B, Aspling M, Janzen V, Adams GB, Curto M, McClatchey AI, Schipani E, Scadden DT
Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture.
Cell Stem Cell 3: 221-7 (2008)
PM ID: 18682243
136: Cozen W, Ferreira MA
Understanding the asthma epidemic: can twin studies help?
Twin Res Hum Genet 11: 111 (2008)
PM ID: 18361710
137: Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A
Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos.
Blood 112: 1720-9 (2008)
PM ID: 18559979 PMC2518882
138: Stock W, La M, Sanford B, Bloomfield CD, Vardiman JW, Gaynon PS, Larson RA, Nachman J, Children's Cancer Group , Cancer and Leukemia Group B studies
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Blood 112: 1646-54 (2008)
PM ID: 18502832 PMC2518876
139: Yoo CB, Chuang JC, Byun HM, Egger G, Yang AS, Dubeau L, Long TI, Laird PW, Marquez VE, Jones PA
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice.
Cancer Prev Res (Phila Pa) 1: 233-40 (2008)
PM ID: 19138966
140: Yavrouian EJ, Sinha UK, Rice DH, Salam MT, Gill PS, Masood R
The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg 134: 985-91 (2008)
PM ID: 18794445
141: Lai CK, Jeng KS, Machida K, Lai MM
Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A.
J Virol 82: 8838-48 (2008)
PM ID: 18562541 PMC2519648
142: Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, Ansell SM, Hartge P, Severson RK, Rothman N, Davis S, Geyer SM, Cozen W, Chanock SJ, Cerhan JR
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
Blood 112: 2694-702 (2008)
PM ID: 18633131 PMC2556607
143: Yi SJ, Lee HT, Groffen J, Heisterkamp N
Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
Int J Mol Med 22: 453-8 (2008)
PM ID: 18813851
144: Adams GB
Myeloproliferative disorder by TKO.
Cell Stem Cell 3: 361-2 (2008)
PM ID: 18940726
145: Tagawa ST, Dorff TB, Rochanda L, Ye W, Boyle S, Raghavan D, Lieskovsky G, Skinner DG, Quinn DI, Liebman HA
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.
BJU Int 102: 1086-91 (2008)
PM ID: 18671791
146: Longo VD, Lieber MR, Vijg J
Turning anti-ageing genes against cancer.
Nat Rev Mol Cell Biol 9: 903-10 (2008)
PM ID: 18946478
147: Gajecka M, Gentles AJ, Tsai AG, Chitayat D, Mackay KL, Glotzbach CD, Lieber MR, Shaffer LG
Unexpected complexity at breakpoint junctions in phenotypically normal individuals and mechanisms involved in generating balanced translocations t(1;22)(p36;q13).
Genome Res 18: 1733-42 (2008)
PM ID: 18765821 PMC2577863
148: Harned TM, Gaynon PS
Relapsed acute lymphoblastic leukemia: current status and future opportunities.
Curr Oncol Rep 10: 453-8 (2008)
PM ID: 18928659
149: Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels EA, Hein DW, Hill DA, Kelemen LE, Lim U, Lynch CF, Schenk M, Wacholder S, Ward MH, Hoar Zahm S, Chanock SJ, Cerhan JR, Hartge P
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
Blood 112: 5150-60 (2008)
PM ID: 18796628 PMC2597610 [Available on 12/15/09]
150: Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR
Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.
Cell 135: 1130-42 (2008)
PM ID: 19070581 PMC2642632 [Available on 12/12/09] NIHMS84558 [Available on 12/12/09]
151: Nguyen K, Devidas M, Cheng SC, La M, Raetz EA, Carroll WL, Winick NJ, Hunger SP, Gaynon PS, Loh ML, Children's Oncology Group
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.
Leukemia 22: 2142-50 (2008)
PM ID: 18818707
152: Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini R, Ferrari S, Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP, Soverini S, Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A, Chiaretti S, Müschen M, Foà R, Baccarani M, Martinelli G
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
Haematologica 93: 1814-21 (2008)
PM ID: 18838475
153: Douer D
Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
Best Pract Res Clin Haematol 21: 647-58 (2008)
PM ID: 19041604
154: Di Iorgi N, Mittelman SD, Gilsanz V
Differential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adults.
Int J Obes (Lond) 32: 1854-60 (2008)
PM ID: 18838978 PMC2605198 NIHMS67759
155: Sharabi AB, Aldrich M, Sosic D, Olson EN, Friedman AD, Lee SH, Chen SY
Twist-2 controls myeloid lineage development and function.
PLoS Biol 6: e316 (2008)
PM ID: 19090621
156: Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich AE, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
PLoS One 4: e5360 (2009)
PM ID: 19390683 PMC2669130
157: Cheung E, Liebman HA
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia.
Biologics 3: 57-62 (2009)
PM ID: 19707396 PMC2726056
158: Schenk M, Purdue MP, Colt JS, Hartge P, Blair A, Stewart PW, Cerhan JR, De Roos AJ, Cozen W, Severson RK
Occupation/industry and risk of non-Hodgkin's lymphoma in the United States.
Occup Environ Med 66: 23-31 (2009)
PM ID: 18805886
159: Ursin G, Lillie EO, Lee EJ, Cockburn MG, Schork NJ, Cozen W, Parisky YR, Hamilton AS, Astrahan MA, Mack TM
The relative importance of genetics and environment on mammographic density.
Cancer Epidemiol Biomarkers Prev 18: 102-12 (2009)
PM ID: 19124487
160: Lu Y, Sullivan-Halley J, Cozen W, Chang ET, Henderson KD, Ma H, Deapen D, Clarke CA, Reynolds P, Neuhausen SL, Anton-Culver H, Ursin G, West D, Bernstein L
Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study.
Br J Cancer 100: 524-6 (2009)
PM ID: 19156148 PMC2658543 [Available on 02/10/10]
161: Cines DB, Liebman HA, Stasi R
Pathobiology of secondary immune thrombocytopenia.
Semin Hematol 46: S2-14 (2009)
PM ID: 19245930 PMC2682438 [Available on 01/01/10] NIHMS99872 [Available on 01/01/10]
162: Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS
The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.
Blood 113: 254-63 (2009)
PM ID: 18836096 PMC2614637 [Available on 01/01/10]
163: Purdue MP, Lan Q, Wang SS, Kricker A, Menashe I, Zheng TZ, Hartge P, Grulich AE, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Leaderer BP, Cerhan JR, Yeager M, Cozen W, Jacobs KB, Davis S, Rothman N, Chanock SJ, Chatterjee N, Armstrong BK
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
Carcinogenesis 30: 275-81 (2009)
PM ID: 19029192 PMC2639046 [Available on 02/01/10]
164: Pullarkat ST, Danley KL, Bernstein L, Brynes RK, Cozen W
High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California.
Cancer Epidemiol Biomarkers Prev 18: 611-5 (2009)
PM ID: 19208664
165: Colt JS, Rothman N, Severson RK, Hartge P, Cerhan JR, Chatterjee N, Cozen W, Morton LM, De Roos AJ, Davis S, Chanock SJ, Wang SS
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
Blood 113: 1899-905 (2009)
PM ID: 19066394 PMC2651009
166: de Villartay JP, Shimazaki N, Charbonnier JB, Fischer A, Mornon JP, Lieber MR, Callebaut I
A histidine in the beta-CASP domain of Artemis is critical for its full in vitro and in vivo functions.
DNA Repair (Amst) 8: 202-8 (2009)
PM ID: 19022407
167: Wang SS, Maurer MJ, Morton LM, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Hartge P, Cerhan JR
Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
Leukemia 23: 596-602 (2009)
PM ID: 18830263
168: Tsai AG, Engelhart AE, Hatmal MM, Houston SI, Hud NV, Haworth IS, Lieber MR
Conformational variants of duplex DNA correlated with cytosine-rich chromosomal fragile sites.
J Biol Chem 284: 7157-64 (2009)
PM ID: 19106104 PMC2652318 [Available on 03/13/10]
169: Kondo Y, Machida K, Liu HM, Ueno Y, Kobayashi K, Wakita T, Shimosegawa T, Lai MM
Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.
J Infect Dis 199: 726-36 (2009)
PM ID: 19199548
170: Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, Jones P, Yang A, Issa JP
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
Epigenetics 4: 176-84 (2009)
PM ID: 19421002
171: Liu HM, Aizaki H, Choi KS, Machida K, Ou JJ, Lai MM
SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication.
Virology 386: 249-56 (2009)
PM ID: 19232660
172: Gathany AH, Hartge P, Davis S, Cerhan JR, Severson RK, Cozen W, Rothman N, Chanock SJ, Wang SS
Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
Cancer Causes Control : (2009)
PM ID: 19396635
173: Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, Leaderer BP, Grulich AE, Yeager M, Cozen W, Hoar Zahm S, Chanock SJ, Rothman N, Hartge P
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
Cancer Epidemiol Biomarkers Prev 18: 1259-70 (2009)
PM ID: 19336552 PMC2716008 [Available on 04/01/10] NIHMS110222 [Available on 04/01/10]
174: Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, Green MD, Cozen W, Cockburn MG, Sibug Saber M, Topor M, Zeruto C, Abedi-Ardekani B, Reichman ME, Hewitt SM
Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray.
Cancer Res 69: 2950-5 (2009)
PM ID: 19276352 PMC2711977 [Available on 04/01/10] NIHMS103928 [Available on 04/01/10]
175: Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS
Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
Cancer Res 69: 3736-45 (2009)
PM ID: 19366806
176: Adams GB, Alley IR, Chung UI, Chabner KT, Jeanson NT, Lo Celso C, Marsters ES, Chen M, Weinstein LS, Lin CP, Kronenberg HM, Scadden DT
Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow.
Nature 459: 103-7 (2009)
PM ID: 19322176 PMC2761017 NIHMS102683
177: Roy D, Lieber MR
G clustering is important for the initiation of transcription-induced R-loops in vitro, whereas high G density without clustering is sufficient thereafter.
Mol Cell Biol 29: 3124-33 (2009)
PM ID: 19307304 PMC2682002 [Available on 12/01/09]
178: Shimazaki N, Tsai AG, Lieber MR
H3K4me3 stimulates the V(D)J RAG complex for both nicking and hairpinning in trans in addition to tethering in cis: implications for translocations.
Mol Cell 34: 535-44 (2009)
PM ID: 19524534
179: Cines DB, Bussel JB, Liebman HA, Luning Prak ET
The ITP syndrome: pathogenic and clinical diversity.
Blood 113: 6511-21 (2009)
PM ID: 19395674 PMC2710913 [Available on 06/25/10]
180: Lan Q, Morton LM, Armstrong B, Hartge P, Menashe I, Zheng T, Purdue MP, Cerhan JR, Zhang Y, Grulich AE, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer BP, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Wang SS
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
Blood 114: 264-7 (2009)
PM ID: 19414860 PMC2714202 [Available on 07/09/10]
181: Rashidi N, Adams GB
The influence of parathyroid hormone on the adult hematopoietic stem cell niche.
Curr Osteoporos Rep 7: 53-7 (2009)
PM ID: 19631029
182: Masiello D, Tulpule A
Bendamustine therapy in chronic lymphocytic leukemia.
Expert Opin Pharmacother 10: 1687-98 (2009)
PM ID: 19527193
183: Purdue MP, Severson RK, Colt JS, Stewart PW, De Roos AJ, Cerhan JR, Cozen W, Davis S, Hartge P, Schenk M, Blair A
Degreasing and risk of non-Hodgkin lymphoma.
Occup Environ Med 66: 557-60 (2009)
PM ID: 19017696
184: Choi SH, Worswick SD, Byun HM, Shear T, Soussa JC, Wolff EM, Douer D, Garcia-Manero G, Liang G, Yang AS
Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer.
Int J Cancer 125: 723-9 (2009)
PM ID: 19437537
185: Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L, Park EJ, Schuh W, Gruber TA, Herzog S, Kim YM, Hofmann WK, Li AX, Storlazzi CT, Jäck HM, Groffen J, Martinelli G, Heisterkamp N, Jumaa H, Müschen M
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
J Exp Med 206: 1739-53 (2009)
PM ID: 19620627 PMC2722172 [Available on 02/03/10]
186: Vajdic CM, Falster MO, de Sanjose S, Martínez-Maza O, Becker N, Bracci PM, Melbye M, Smedby KE, Engels EA, Turner JS, Vineis P, Costantini AS, Holly EA, Kane E, Spinelli JJ, La Vecchia C, Zheng T, Chiu BC, Dal Maso L, Cocco PL, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson RK, Cerhan JR, Breen EC, Birmann B, Cozen W, Grulich AE
Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
Cancer Res 69: 6482-9 (2009)
PM ID: 19654312 PMC2758272 [Available on 08/15/10] NIHMS128417 [Available on 08/15/10]
187: Leonard RC, Williams S, Tulpule A, Levine AM, Oliveros S
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet).
Breast 18: 218-24 (2009)
PM ID: 19656681
188: Sposto R, Gaynon PS
An adjustment for patient heterogeneity in the design of two-stage phase II trials.
Stat Med 28: 2566-79 (2009)
PM ID: 19521973
189: Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N, Henke N, Li Z, Hoffmann TK, Kim YM, Hofmann WK, Jumaa H, Groffen J, Heisterkamp N, Martinelli G, Lieber MR, Casellas R, Müschen M
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.
Cancer Cell 16: 232-45 (2009)
PM ID: 19732723
190: Lee HR, Kim MH, Lee JS, Liang C, Jung JU
Viral interferon regulatory factors.
J Interferon Cytokine Res 29: 621-7 (2009)
PM ID: 19715458
191: Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD
Reciprocal relations of subcutaneous and visceral fat to bone structure and strength.
J Clin Endocrinol Metab 94: 3387-93 (2009)
PM ID: 19531595 PMC2741723 [Available on 09/01/10]
192: Tsitoura E, Thomas J, Cuchet D, Thoinet K, Mavromara P, Epstein AL
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts.
J Gen Virol 90: 2209-20 (2009)
PM ID: 19515829
193: Mishra S, Zhang B, Cunnick JM, Heisterkamp N, Groffen J
Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells.
Cancer Res 66: 5387-93 (2009)
PM ID: 16707466
194: Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman HA, Mendelson DS, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW, American Society of Clinical Oncology
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
J Clin Oncol 25: 5490-505 (2009)
PM ID: 17968019
195: Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini AM, Heisterkamp N, Mittelman SD
Adipocytes impair leukemia treatment in mice.
Cancer Res 69: 7867-74 (2009)
PM ID: 19773440 PMC2756308 [Available on 10/01/10] NIHMS140247 [Available on 10/01/10]
196: E X, Hwang S, Oh S, Lee JS, Jeong JH, Gwack Y, Kowalik TF, Sun R, Jung JU, Liang C
Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68.
PLoS Pathog 5: e1000609 (2009)
PM ID: 19816569 PMC2752191
197: Chang HM, Wachtman LM, Pearson CB, Lee JS, Lee HR, Lee SH, Vieira J, Mansfield KG, Jung JU
Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection.
PLoS Pathog 5: e1000606 (2009)
PM ID: 19798430 PMC2745662
198: Cunnick JM, Schmidhuber S, Chen G, Yu M, Yi SJ, Cho YJ, Kaartinen V, Minoo P, Warburton D, Groffen J, Heisterkamp N
Bcr and Abr cooperate in negatively regulating acute inflammatory responses.
Mol Cell Biol 29: 5742-50 (2009)
PM ID: 19703997 PMC2772743 [Available on 05/01/10]
199: Cozen W, Hamilton AS, Zhao P, Salam MT, Deapen DM, Nathwani BN, Weiss LM, Mack TM
A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.
Blood 114: 4014-20 (2009)
PM ID: 19738032 PMC2774542 [Available on 11/05/10]
200: Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M, Wang C, Davies SM, Gaynon PS, Trigg M, Rutledge R, Burden L, Jorstad D, Carroll A, Heerema NA, Winick N, Borowitz MJ, Hunger SP, Carroll WL, Camitta B
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
J Clin Oncol 27: 5175-81 (2009)
PM ID: 19805687 PMC2773475 [Available on 11/01/10]
201: Lee JS, Li Q, Lee JY, Lee SH, Jeong JH, Lee HR, Chang H, Zhou FC, Gao SJ, Liang C, Jung JU
FLIP-mediated autophagy regulation in cell death control.
Nat Cell Biol 11: 1355-62 (2009)
PM ID: 19838173 PMC2802862 [Available on 11/01/10] NIHMS165792 [Available on 11/01/10]
202: Xu TX, Sotnikova TD, Liang C, Zhang J, Jung JU, Spealman RD, Gainetdinov RR, Yao WD
Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.
J Neurosci 29: 14086-99 (2009)
PM ID: 19906957 PMC2818669 [Available on 05/11/10] NIHMS163955 [Available on 05/11/10]
203: Nachman JB, La MK, Hunger SP, Heerema NA, Gaynon PS, Hastings C, Mattano LA, Sather H, Devidas M, Freyer DR, Steinherz PG, Seibel NL
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.
J Clin Oncol 27: 5189-94 (2009)
PM ID: 19805689
204: Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Clin Cancer Res 15: 6830-40 (2009)
PM ID: 19861441 PMC2783253 [Available on 11/15/10] NIHMS140312 [Available on 11/15/10]
205: Yi SJ, Groffen J, Heisterkamp N
Transglutaminase 2 regulates the GTPase-activating activity of Bcr.
J Biol Chem 284: 35645-51 (2009)
PM ID: 19840940 PMC2790995 [Available on 12/18/10]
206: Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, Yang AS
Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns.
Hum Mol Genet 18: 4808-17 (2009)
PM ID: 19776032
207: Sumiyoshi T, Holt NG, Hollis RP, Ge S, Cannon PM, Crooks GM, Kohn DB
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Hum Gene Ther 20: 1607-26 (2009)
PM ID: 19689196
208: Machida K, Liu JC, McNamara G, Levine A, Duan L, Lai MM
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway.
J Virol 83: 12590-600 (2009)
PM ID: 19793824 PMC2786750 [Available on 06/01/10]
209: Nowak D, Ogawa S, Müschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, Paquette R, Chang MS, Thoenissen NH, Mossner M, Hofmann WK, Kohlmann A, Weiss T, Haferlach T, Haferlach C, Koeffler HP
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
Blood 115: 1049-53 (2009)
PM ID: 19965645
210: Cheung E, Liebman HA
Thyroid disease in patients with immune thrombocytopenia.
Hematol Oncol Clin North Am 23: 1251-60 (2009)
PM ID: 19932432
211: Cines DB, Liebman HA
The immune thrombocytopenia syndrome: a disorder of diverse pathogenesis and clinical presentation.
Hematol Oncol Clin North Am 23: 1155-61 (2009)
PM ID: 19932425
212: Liebman HA
Preface.
Hematol Oncol Clin North Am 23: xi (2009)
PM ID: 19932424
213: Nahar R, Müschen M
Pre-B cell receptor signaling in acute lymphoblastic leukemia.
Cell Cycle 8: 3874-7 (2009)
PM ID: 19901533
214: Armenian SH, Nash KA, Kapoor N, Franklin JL, Gaynon PS, Ross LA, Hoffman JA
Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
J Pediatr Hematol Oncol 31: 920-6 (2009)
PM ID: 19855303
215: Lieber MR, Gu J, Lu H, Shimazaki N, Tsai AG
Nonhomologous DNA End Joining (NHEJ) and Chromosomal Translocations in Humans.
Subcell Biochem 50: 279-96 (2010)
PM ID: 20012587
216: Tsai AG, Lieber MR
Mechanisms of chromosomal rearrangement in the human genome.
BMC Genomics 11 Suppl 1: S1 (2010)
PM ID: 20158866 PMC2822523
217: Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.
PLoS Genet 6: e1000917 (2010)
PM ID: 20421991 PMC2858672
218: Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
Retrovirology 7: 51 (2010)
PM ID: 20529266 PMC2890665
219: Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
BMC Cancer 10: 641 (2010)
PM ID: 21092311 PMC3001720
220: Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, Brulois KF, Lee S, Buckley JD, Laird PW, Marquez VE, Jung JU
Epigenetic analysis of KSHV latent and lytic genomes.
PLoS Pathog 6: e1001013 (2010)
PM ID: 20661424 PMC2908616
221: Fei F, Kweon SM, Haataja L, De Sepulveda P, Groffen J, Heisterkamp N
The Fer tyrosine kinase regulates interactions of Rho GDP-Dissociation Inhibitor α with the small GTPase Rac.
BMC Biochem 11: 48 (2010)
PM ID: 21122136 PMC3009610
222: He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR
Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.
Invest Ophthalmol Vis Sci 51: 543-52 (2010)
PM ID: 19696168 PMC2828363 [Available on 01/01/11] NIHMS173696 [Available on 01/01/11]
223: De Roos AJ, Davis S, Colt JS, Blair A, Airola M, Severson RK, Cozen W, Cerhan JR, Hartge P, Nuckols JR, Ward MH
Residential proximity to industrial facilities and risk of non-Hodgkin lymphoma.
Environ Res 110: 70-8 (2010)
PM ID: 19840879 PMC2795078 [Available on 01/01/11] NIHMS153621 [Available on 01/01/11]
224: Roy D, Zhang Z, Lu Z, Hsieh CL, Lieber MR
Competition between the RNA transcript and the nontemplate DNA strand during R-loop formation in vitro: a nick can serve as a strong R-loop initiation site.
Mol Cell Biol 30: 146-59 (2010)
PM ID: 19841062 PMC2798282 [Available on 07/01/10]
225: Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS
KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.
Blood 115: 887-95 (2010)
PM ID: 19965636 PMC2815507 [Available on 01/28/11]
226: Gebregziabher M, Guimaraes P, Cozen W, Conti DV
A polytomous conditional likelihood approach for combining matched and unmatched case-control studies.
Stat Med : (2010)
PM ID: 20069625
227: Lieber MR
The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway.
Annu Rev Biochem : (2010)
PM ID: 20192759
228: Oh S, E X, Hwang S, Liang C
Autophagy evasion in herpesviral latency.
Autophagy 6: 151-2 (2010)
PM ID: 19923915 PMC2847627 [Available on 07/04/10] NIHMS188706 [Available on 07/04/10]
229: Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
J Clin Oncol 28: 648-54 (2010)
PM ID: 19841326 PMC2815999 [Available on 02/01/11]
230: Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P, Zhang L, Armstrong B, Smith A, Shiao R, Novak AJ, Maynadie M, Chanock SJ, Staines A, Holford TR, Holly EA, Rothman N, Wang SS
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
Am J Epidemiol 171: 267-76 (2010)
PM ID: 20047977
231: Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
J Clin Oncol 28: 549-55 (2010)
PM ID: 20026805
232: Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN, Hunger SP, Devidas M, Children's Oncology Group
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.
Leukemia 24: 285-97 (2010)
PM ID: 20016531
233: Wang A, Alimova IN, Luo P, Jong A, Triche TJ, Wu L
Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.
FASEB J 24: 833-43 (2010)
PM ID: 19917671 PMC2830139 [Available on 03/01/11]
234: Wang XM, Greiner TC, Bibikova M, Pike BL, Siegmund KD, Sinha UK, Müschen M, Jaeger EB, Weisenburger DD, Chan WC, Shibata D, Fan JB, Hacia JG
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
J Cell Biochem 109: 818-27 (2010)
PM ID: 20069569
235: Naik AK, Lieber MR, Raghavan SC
Cytosines, but not purines, determine recombination activating gene (RAG)-induced breaks on heteroduplex DNA structures: implications for genomic instability.
J Biol Chem 285: 7587-97 (2010)
PM ID: 20051517 PMC2844206 [Available on 03/05/11]
236: Punj V, Matta H, Schamus S, Tamewitz A, Anyang B, Chaudhary PM
Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a.
Oncogene 29: 1835-44 (2010)
PM ID: 20023696 PMC2845732 [Available on 09/25/10] NIHMS159454 [Available on 09/25/10]
237: Fei F, Stoddart S, Müschen M, Kim YM, Groffen J, Heisterkamp N
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia.
Leukemia 24: 813-20 (2010)
PM ID: 20111071
238: Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS
Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.
Am J Pathol 176: 2029-38 (2010)
PM ID: 20133814 PMC2843490 [Available on 04/01/11]
239: Gu J, Li S, Zhang X, Wang LC, Niewolik D, Schwarz K, Legerski RJ, Zandi E, Lieber MR
DNA-PKcs regulates a single-stranded DNA endonuclease activity of Artemis.
DNA Repair (Amst) 9: 429-37 (2010)
PM ID: 20117966 PMC2847011 [Available on 04/04/11] NIHMS171326 [Available on 04/04/11]
240: Gack MU, Nistal-Villán E, Inn KS, García-Sastre A, Jung JU
Phosphorylation-mediated negative regulation of RIG-I antiviral activity.
J Virol 84: 3220-9 (2010)
PM ID: 20071582 PMC2838087 [Available on 10/01/10]
241: Liang C, Jung JU
Autophagy genes as tumor suppressors.
Curr Opin Cell Biol 22: 226-33 (2010)
PM ID: 19945837 PMC2854193 [Available on 04/01/11] NIHMS159173 [Available on 04/01/11]
242: Stork LC, Matloub Y, Broxson E, La M, Yanofsky R, Sather H, Hutchinson R, Heerema NA, Sorrell AD, Masterson M, Bleyer A, Gaynon PS
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
Blood 115: 2740-8 (2010)
PM ID: 20124218 PMC2854423 [Available on 04/08/11]
243: Tsai AG, Lu Z, Lieber MR
The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not.
Blood 115: 3640-1; author reply 3641-2 (2010)
PM ID: 20430965 PMC2867271 [Available on 04/29/11]
244: Lieber MR
NHEJ and its backup pathways in chromosomal translocations.
Nat Struct Mol Biol 17: 393-5 (2010)
PM ID: 20368722
245: Müschen M
Genetic relicts from the origin of ALL.
Blood 115: 3424-5 (2010)
PM ID: 20430963
246: Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP, Davis S, Schenk M, Chanock SJ, Hartge P, Carrington M, Wang SS
Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.
Leukemia 24: 1055-8 (2010)
PM ID: 20147981
247: Mittelman SD, Klier K, Braun S, Azen C, Geffner ME, Buchanan TA
Obese adolescents show impaired meal responses of the appetite-regulating hormones ghrelin and PYY.
Obesity (Silver Spring) 18: 918-25 (2010)
PM ID: 20094039
248: Behan JW, Avramis VI, Yun JP, Louie SG, Mittelman SD
Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice.
Pharmacol Res 61: 385-90 (2010)
PM ID: 20083201 PMC2848885 [Available on 05/01/11] NIHMS177512 [Available on 05/01/11]
249: Zhang Y, Liu R, Ni M, Gill P, Lee AS
Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP.
J Biol Chem 285: 15065-75 (2010)
PM ID: 20208072 PMC2865300 [Available on 05/14/11]
250: Wu AH, Siegmund KD, Long TI, Cozen W, Wan P, Tseng CC, Shibata D, Laird PW
Hormone therapy, DNA methylation and colon cancer.
Carcinogenesis 31: 1060-7 (2010)
PM ID: 20064828 PMC2878358 [Available on 06/01/11]
251: Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, Mackman N
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Thromb Res 125: 511-2 (2010)
PM ID: 19854471 PMC2878897 [Available on 06/01/11] NIHMS149553 [Available on 06/01/11]
252: Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, Lynch CF, Wang SS, Maurer MJ, Hartge P, Cerhan JR
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
Cancer 116: 2993-3000 (2010)
PM ID: 20564404 PMC2889918 [Available on 06/01/11] NIHMS182481 [Available on 06/01/11]
253: Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
Blood 115: 4820-3 (2010)
PM ID: 20385791 PMC2890176 [Available on 06/10/11]
254: Duy C, Yu JJ, Nahar R, Swaminathan S, Kweon SM, Polo JM, Valls E, Klemm L, Shojaee S, Cerchietti L, Schuh W, Jäck HM, Hurtz C, Ramezani-Rad P, Herzog S, Jumaa H, Koeffler HP, de Alborán IM, Melnick AM, Ye BH, Müschen M
BCL6 is critical for the development of a diverse primary B cell repertoire.
J Exp Med 207: 1209-21 (2010)
PM ID: 20498019 PMC2882829 [Available on 12/07/10]
255: Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N
A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
Cancer Res 70: 4346-56 (2010)
PM ID: 20460528 PMC2880197 [Available on 06/01/11] NIHMS192821 [Available on 06/01/11]
256: Nistal-Villán E, Gack MU, Martínez-Delgado G, Maharaj NP, Inn KS, Yang H, Wang R, Aggarwal AK, Jung JU, García-Sastre A
Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.
J Biol Chem 285: 20252-61 (2010)
PM ID: 20406818 PMC2888438
257: Tolstov YL, Arora R, Scudiere SC, Busam K, Chaudhary PM, Chang Y, Moore PS
Lack of evidence for direct involvement of Merkel cell polyomavirus (MCV) in chronic lymphocytic leukemia (CLL).
Blood 115: 4973-4 (2010)
PM ID: 20538816 PMC2890166 [Available on 06/10/11]
258: Horton TM, Sposto R, Brown P, Reynolds CP, Hunger SP, Winick NJ, Raetz EA, Carroll WL, Arceci RJ, Borowitz MJ, Gaynon PS, Gore L, Jeha S, Maurer BJ, Siegel SE, Biondi A, Kearns PR, Narendran A, Silverman LB, Smith MA, Zwaan CM, Whitlock JA, ALLNA 2008 Conference
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.
Pediatr Blood Cancer 54: 872-8 (2010)
PM ID: 20127846 PMC2857540 [Available on 07/01/11] NIHMS163748 [Available on 07/01/11]
259: Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.
Blood 116: 297-305 (2010)
PM ID: 20442363 PMC2910613 [Available on 07/15/11]
260: Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, Oldenburg J, Cannon PM
Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
J Virol 84: 7243-55 (2010)
PM ID: 20444895 PMC2898217
261: Adams GB
Stem cells hold their breath.
Blood 116: 307-8 (2010)
PM ID: 20651077
262: Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
Cancer 116: 3969-77 (2010)
PM ID: 20564162
263: Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Nat Biotechnol 28: 839-47 (2010)
PM ID: 20601939
264: Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, Machida K, Lai MM
Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A.
J Virol 84: 7983-93 (2010)
PM ID: 20534861 PMC2916529
265: Rabin DU, Kuter DJ, Liebman HA, Bussel JB
What do healthcare providers ask their patients with immune thrombocytopenia?
Am J Hematol 85: 629-31 (2010)
PM ID: 20658595
266: Shibata D, Lieber MR
Is there any genetic instability in human cancer?
DNA Repair (Amst) 9: 858; discussion 859-60 (2010)
PM ID: 20605538 PMC2914198 [Available on 08/01/11] NIHMS206531 [Available on 08/01/11]
267: Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Hepatology 52: 480-92 (2010)
PM ID: 20683948
268: Lieber MR, Wilson TE
SnapShot: Nonhomologous DNA end joining (NHEJ).
Cell 142: 496-496.e1 (2010)
PM ID: 20691907
269: Lechner MG, Liebertz DJ, Epstein AL
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
J Immunol 185: 2273-84 (2010)
PM ID: 20644162 PMC2923483 [Available on 08/01/11] NIHMS223953 [Available on 08/01/11]
270: Tsai AG, Yoda A, Weinstock DM, Lieber MR
t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not.
Blood 116: 1993-4 (2010)
PM ID: 20847213
271: Gorman MF, Ji L, Ko RH, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
Pediatr Blood Cancer 55: 421-9 (2010)
PM ID: 20658611
272: Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU
Immune evasion by Kaposi's sarcoma-associated herpesvirus.
Future Microbiol 5: 1349-65 (2010)
PM ID: 20860481
273: Yun JP, Behan JW, Heisterkamp N, Butturini A, Klemm L, Ji L, Groffen J, Müschen M, Mittelman SD
Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models.
Cancer Prev Res (Phila) 3: 1259-64 (2010)
PM ID: 20823291 PMC2955776 [Available on 10/01/11] NIHMS227757 [Available on 10/01/11]
274: Tallman M, Douer D, Gore S, Powell BL, Ravandi F, Rowe J, Ranganathan A, Sanz MA
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy.
Clin Lymphoma Myeloma Leuk 10: S122-6 (2010)
PM ID: 21115429
275: Gruber TA, Chang MS, Sposto R, Müschen M
Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.
Cancer Res 70: 7411-20 (2010)
PM ID: 20876806 PMC2948648 [Available on 10/01/11] NIHMS228027 [Available on 10/01/11]
276: Bernstein I, Byun HM, Mohrbacher A, Douer D, Gorospe G, Hergesheimer J, Groshen S, O'Connell C, Yang AS
A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation.
Epigenetics 5: 750-7 (2010)
PM ID: 20861661
277: Fang C, Wang Y, Vu NT, Lin WY, Hsieh YT, Rubbi L, Phelps ME, Müschen M, Kim YM, Chatziioannou AF, Tseng HR, Graeber TG
Integrated microfluidic and imaging platform for a kinase activity radioassay to analyze minute patient cancer samples.
Cancer Res 70: 8299-308 (2010)
PM ID: 20837665
278: Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, Robinson LJ, Gill PS, Chaudhary P
Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.
Cancer Biol Ther 10: 1033-40 (2010)
PM ID: 20818173
279: Lai CK, Jeng KS, Machida K, Lai MM
Hepatitis C virus egress and release depend on endosomal trafficking of core protein.
J Virol 84: 11590-8 (2010)
PM ID: 20739534 PMC2953145 [Available on 05/01/11]
280: Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR, Epstein AL
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
Cancer : (2010)
PM ID: 21061340
281: Machida K, McNamara G, Cheng KT, Huang J, Wang CH, Comai L, Ou JH, Lai MM
Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes.
J Immunol 185: 6985-98 (2010)
PM ID: 20974981 PMC3101474 NIHMS293685
282: Wilson WH, O'Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, Tulpule A, Dunleavy K, Xiong H, Chiu YL, Cui Y, Busman T, Elmore SW, Rosenberg SH, Krivoshik AP, Enschede SH, Humerickhouse RA
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
Lancet Oncol 11: 1149-59 (2010)
PM ID: 21094089 PMC3025495 [Available on 10/01/11] NIHMS256117 [Available on 10/01/11]
283: Kim HJ, Lee S, Jung JU
When autophagy meets viruses: a double-edged sword with functions in defense and offense.
Semin Immunopathol 32: 323-41 (2010)
PM ID: 20865416
284: Joo CH, Lee U, Nam YR, Jung JU, Lee H, Cho YK, Kim YK
Gene therapeutic approach for inhibiting hepatitis C virus replication using a recombinant protein that controls interferon expression.
Antimicrob Agents Chemother 54: 5048-56 (2010)
PM ID: 20855734 PMC2981247
285: Lam BS, Adams GB
Hematopoietic stem cell lodgment in the adult bone marrow stem cell niche.
Int J Lab Hematol 32: 551-8 (2010)
PM ID: 20682000
286: Yi SJ, Groffen J, Heisterkamp N
Bcr is a substrate for Transglutaminase 2 cross-linking activity.
BMC Biochem 12: 8 (2011)
PM ID: 21310073 PMC3044668
287: Luo B, Lam BS, Lee SH, Wey S, Zhou H, Wang M, Chen SY, Adams GB, Lee AS
The endoplasmic reticulum chaperone protein GRP94 is required for maintaining hematopoietic stem cell interactions with the adult bone marrow niche.
PLoS One 6: e20364 (2011)
PM ID: 21647226 PMC3101259
288: Wang X, Kang GH, Campan M, Weisenberger DJ, Long TI, Cozen W, Bernstein L, Wu AH, Siegmund KD, Shibata D, Laird PW
Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors.
PLoS One 6: e25985 (2011)
PM ID: 22028801 PMC3197593
289: Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
Retrovirology 8: 85 (2011)
PM ID: 22026928 PMC3214836
290: Yang SJ, Lopez LA, Exline CM, Haworth KG, Cannon PM
Lack of adaptation to human tetherin in HIV-1 group O and P.
Retrovirology 8: 78 (2011)
PM ID: 21955466 PMC3192746
291: Liu SV, Douer D
Reply.
Acta Haematol 126: 240 (2011)
PM ID: 21952727
292: Pirooz SD, Lee JH, Zhao Z, Ni D, Oh S, Liang C
Measurement of γHV68 Infection in Mice.
J Vis Exp : (2011)
PM ID: 22127138
293: Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T, Epstein AL
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
J Transl Med 9: 90 (2011)
PM ID: 21658270 PMC3128058
294: Lu Y, Abdou AM, Cerhan JR, Morton LM, Severson RK, Davis S, Cozen W, Rothman N, Bernstein L, Chanock S, Hartge P, Wang SS
Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
ScientificWorldJournal 11: 2062-70 (2011)
PM ID: 22125456 PMC3217596
295: Wang SS, Lu Y, Rothman N, Abdou AM, Cerhan JR, De Roos A, Davis S, Severson RK, Cozen W, Chanock SJ, Bernstein L, Morton LM, Hartge P
Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
PLoS One 6: e26949 (2011)
PM ID: 22096508 PMC3212525
296: Reece DE, Sullivan D, Lonial S, Mohrbacher AF, Chatta G, Shustik C, Burris H, Venkatakrishnan K, Neuwirth R, Riordan WJ, Karol M, von Moltke LL, Acharya M, Zannikos P, Keith Stewart A
Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma.
Cancer Chemother Pharmacol 67: 57-67 (2011)
PM ID: 20306195
297: Lam BS, Cunningham C, Adams GB
Pharmacologic modulation of the calcium-sensing receptor enhances hematopoietic stem cell lodgment in the adult bone marrow.
Blood 117: 1167-75 (2011)
PM ID: 21076044 PMC3056470 [Available on 01/27/12]
298: Liebman H, Khorana A, Kessler C
Clinical roundtable monograph. The oncologist's role in management of venous thromboembolism.
Clin Adv Hematol Oncol 9: suppl 1-15 (2011)
PM ID: 21361081
299: Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
Cancer Epidemiol Biomarkers Prev 20: 42-9 (2011)
PM ID: 21148756
300: Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS
Identification of preferential target sites for human DNA methyltransferases.
Nucleic Acids Res 39: 104-18 (2011)
PM ID: 20841325 PMC3017615
301: O'Connell C, Razavi P, Ghalichi M, Boyle S, Vasan S, Mark L, Caton A, Duddalwar V, Boswell W, Grabow K, Liebman HA
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning.
J Thromb Haemost 9: 305-11 (2011)
PM ID: 20955348
302: Nambiar M, Goldsmith G, Moorthy BT, Lieber MR, Joshi MV, Choudhary B, Hosur RV, Raghavan SC
Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma.
Nucleic Acids Res 39: 936-48 (2011)
PM ID: 20880994 PMC3035451
303: Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON, Colicelli J
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.
Leukemia 25: 290-300 (2011)
PM ID: 21102429
304: Purdue MP, Bakke B, Stewart P, De Roos AJ, Schenk M, Lynch CF, Bernstein L, Morton LM, Cerhan JR, Severson RK, Cozen W, Davis S, Rothman N, Hartge P, Colt JS
A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma.
Environ Health Perspect 119: 232-8 (2011)
PM ID: 21370516
305: Hong B, Song XT, Rollins L, Berry L, Huang XF, Chen SY
Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.
J Clin Invest 121: 739-51 (2011)
PM ID: 21206085 PMC3026719
306: Inn KS, Gack MU, Tokunaga F, Shi M, Wong LY, Iwai K, Jung JU
Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction.
Mol Cell 41: 354-65 (2011)
PM ID: 21292167 PMC3070481 [Available on 02/04/12] NIHMS263182 [Available on 02/04/12]
307: Oh S, Pirooz SD, Ni D, Zhao Z, Liang C
Anti-autophagic Bcl-2: Not just an innocent bystander.
Autophagy 7: 231-2 (2011)
PM ID: 21099349
308: Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, Armstrong B
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
Br J Haematol 152: 721-726 (2011)
PM ID: 21250972
309: Freyer DR, Devidas M, La M, Carroll WL, Gaynon PS, Hunger SP, Seibel NL
Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
Blood 117: 3010-5 (2011)
PM ID: 21193696 PMC3062307 [Available on 03/17/12]
310: Stanford SM, Krishnamurthy D, Falk MD, Messina R, Debnath B, Li S, Liu T, Kazemi R, Dahl R, He Y, Yu X, Chan AC, Zhang ZY, Barrios AM, Woods VL, Neamati N, Bottini N
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.
J Med Chem 54: 1640-54 (2011)
PM ID: 21341673 PMC3086468 [Available on 03/24/12] NIHMS276264 [Available on 03/24/12]
311: Wren TA, Chung SA, Dorey FJ, Bluml S, Adams GB, Gilsanz V
Bone marrow fat is inversely related to cortical bone in young and old subjects.
J Clin Endocrinol Metab 96: 782-6 (2011)
PM ID: 21177790
312: Ku B, Liang C, Jung JU, Oh BH
Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.
Cell Res 21: 627-41 (2011)
PM ID: 21060336
313: Chandra HS, Heisterkamp NC, Hungerford A, Morrissette JJ, Nowell PC, Rowley JD, Testa JR
Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome.
Cancer Genet 204: 171-9 (2011)
PM ID: 21536234 PMC3092778 [Available on 04/01/12] NIHMS289159 [Available on 04/01/12]
314: Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR, Brooks-Wilson AR, Rehnberg E, Irwan ID, Ryder LP, Brown PN, Bracci PM, Agana L, Riby J, Cozen W, Davis S, Hartge P, Morton LM, Severson RK, Wang SS, Slager SL, Fredericksen ZS, Novak AJ, Kay NE, Habermann TM, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Leach S, Spinelli JJ, Smith MT, Chanock SJ, Padyukov L, Alfredsson L, Klareskog L, Glimelius B, Melbye M, Liu ET, Adami HO, Humphreys K, Liu J
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
PLoS Genet 7: e1001378 (2011)
PM ID: 21533074 PMC3080853
315: Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR, Epstein AL
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
Cancer 117: 1478-89 (2011)
PM ID: 21425149
316: Lam BS, Adams GB
Blocking HIF1α activity eliminates hematological cancer stem cells.
Cell Stem Cell 8: 354-6 (2011)
PM ID: 21474097
317: Lechner MG, Epstein AL
A new mechanism for blocking myeloid-derived suppressor cells by CpG.
Clin Cancer Res 17: 1645-8 (2011)
PM ID: 21288925
318: Lan Q, Wang SS, Menashe I, Armstrong B, Zhang Y, Hartge P, Purdue MP, Holford TR, Morton LM, Kricker A, Cerhan JR, Grulich A, Cozen W, Zahm SH, Yeager M, Vajdic CM, Schenk M, Leaderer B, Yuenger J, Severson RK, Chatterjee N, Chanock SJ, Zheng T, Rothman N
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
Br J Haematol 153: 341-50 (2011)
PM ID: 21418175 PMC3075370 NIHMS246083
319: Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S, Klemm L, Kweon SM, Nahar R, Braig M, Park E, Kim YM, Hofmann WK, Herzog S, Jumaa H, Koeffler HP, Yu JJ, Heisterkamp N, Graeber TG, Wu H, Ye BH, Melnick A, Müschen M
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.
Nature 473: 384-8 (2011)
PM ID: 21593872
320: Wheeler DC, De Roos AJ, Cerhan JR, Morton LM, Severson R, Cozen W, Ward MH
Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study.
Environ Health 10: 63 (2011)
PM ID: 21718483
321: Matta H, Gopalakrishnan R, Punj V, Yi H, Suo Y, Chaudhary PM
A20 Is Induced by Kaposi Sarcoma-associated Herpesvirus-encoded Viral FLICE Inhibitory Protein (vFLIP) K13 and Blocks K13-induced Nuclear Factor-{kappa}B in a Negative Feedback Manner.
J Biol Chem 286: 21555-64 (2011)
PM ID: 21531730 PMC3122214 [Available on 06/17/12]
322: Matloub Y, Bostrom BC, Hunger SP, Stork LC, Angiolillo A, Sather H, La M, Gastier-Foster JM, Heerema NA, Sailer S, Buckley PJ, Thomson B, Cole C, Nachman JB, Reaman G, Winick N, Carroll WL, Devidas M, Gaynon PS
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 118: 243-51 (2011)
PM ID: 21562038 PMC3138679 [Available on 07/14/12]
323: Park E, Gang EJ, Hsieh YT, Schaefer P, Chae S, Klemm L, Huantes S, Loh M, Conway EM, Kang ES, Hoe Koo H, Hofmann WK, Heisterkamp N, Pelus L, Keerthivasan G, Crispino J, Kahn M, Müschen M, Kim YM
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.
Blood 118: 2191-9 (2011)
PM ID: 21715311 PMC3162353 [Available on 08/25/12]
324: Parameswaran R, Yu M, Lim M, Groffen J, Heisterkamp N
Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.
Leukemia 25: 1314-23 (2011)
PM ID: 21483439 PMC3135709 [Available on 02/01/12] NIHMS277153 [Available on 02/01/12]
325: Somlo G, Lashkari A, Bellamy W, Zimmerman TM, Tuscano JM, O'Donnell MR, Mohrbacher AF, Forman SJ, Frankel P, Chen HX, Doroshow JH, Gandara DR
Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.
Br J Haematol 154: 533-5 (2011)
PM ID: 21517811
326: Yang Y, Groshong JS, Matta H, Gopalakrishnan R, Yi H, Chaudhary PM
Constitutive NF-kappaB activation confers interleukin 6 (IL6) independence and resistance to dexamethasone and Janus kinase inhibitor INCB018424 in murine plasmacytoma cells.
J Biol Chem 286: 27988-97 (2011)
PM ID: 21705340 PMC3151044 [Available on 08/12/12]
327: Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, Yasui Y, Bhatia S, Strong LC, Domchek SM, Nathanson KL, Olopade OI, Huang RS, Mack TM, Conti DV, Offit K, Cozen W, Robison LL, Onel K
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.
Nat Med 17: 941-3 (2011)
PM ID: 21785431
328: Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, Lynch CF, Rothman N, Chatterjee N, Yu K, Staudt LM, Weisenburger DD, Wang SS
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
Int J Mol Epidemiol Genet 2: 245-52 (2011)
PM ID: 21915363 PMC3166152
329: International Multiple Sclerosis Genetics Consortium , Wellcome Trust Case Control Consortium 2 , Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'Alfonso S, Blackburn H, Boneschi FM, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppä V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Rückert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sørensen PS, Søndergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvänen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Nature 476: 214-9 (2011)
PM ID: 21833088 PMC3182531 [Available on 02/11/12]
330: Chang CM, Wang SS, Dave BJ, Jain S, Vasef MA, Weisenburger DD, Cozen W, Davis S, Severson RK, Lynch CF, Rothman N, Cerhan JR, Hartge P, Morton LM
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
Int J Cancer 129: 938-47 (2011)
PM ID: 20949561 PMC3125462 [Available on 08/15/12] NIHMS272420 [Available on 08/15/12]
331: Gaynon PS
James B. Nachman, 1948 to 2011: a remembrance.
J Pediatr Hematol Oncol 33: 403-5 (2011)
PM ID: 21792033
332: Lee G, Liang C, Park G, Jang C, Jung JU, Chung J
UVRAG is required for organ rotation by regulating Notch endocytosis in Drosophila.
Dev Biol 356: 588-97 (2011)
PM ID: 21729695
333: Sykes DB, Schroyens W, O'Connell C
The TEMPI syndrome--a novel multisystem disease.
N Engl J Med 365: 475-7 (2011)
PM ID: 21812700
334: Russell SM, Lechner MG, Gong L, Megiel C, Liebertz DJ, Masood R, Correa AJ, Han J, Puri RK, Sinha UK, Epstein AL
USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics.
Oral Oncol 47: 810-7 (2011)
PM ID: 21719345 PMC3164740 [Available on 09/01/12] NIHMS308836 [Available on 09/01/12]
335: Inn KS, Lee SH, Rathbun JY, Wong LY, Toth Z, Machida K, Ou JH, Jung JU
Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.
J Virol 85: 10899-904 (2011)
PM ID: 21835791 PMC3187500 [Available on 04/01/12]
336: Li S, Kanno S, Watanabe R, Ogiwara H, Kohno T, Watanabe G, Yasui A, Lieber MR
Polynucleotide kinase and aprataxin-like forkhead-associated protein (PALF) acts as both a single-stranded DNA endonuclease and a single-stranded DNA 3' exonuclease and can participate in DNA end joining in a biochemical system.
J Biol Chem 286: 36368-77 (2011)
PM ID: 21885877 PMC3196146 [Available on 10/21/12]
337: Gaynon PS
A remembrance: James B. Nachman 1948-2011.
Pediatr Blood Cancer 57: 533-4 (2011)
PM ID: 21826779
338: Kingston D, Chang H, Ensser A, Lee HR, Lee J, Lee SH, Jung JU, Cho NH
Inhibition of retromer activity by herpesvirus saimiri tip leads to CD4 downregulation and efficient T cell transformation.
J Virol 85: 10627-38 (2011)
PM ID: 21849449 PMC3187508 [Available on 04/01/12]
339: O'Connell CL, Razavi PA, Liebman HA
Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism.
J Clin Oncol 29: 4208-9; author reply 4209-10 (2011)
PM ID: 21969510
340: Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
J Clin Oncol 29: 4294-301 (2011)
PM ID: 21969503 PMC3221528 [Available on 11/10/12]
341: Noetzli LJ, Panigrahy A, Mittelman SD, Hyderi A, Dongelyan A, Coates TD, Wood JC
Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Am J Hematol : (2011)
PM ID: 22213195
342: Hijiya N, Thomson B, Isakoff MS, Silverman LB, Steinherz PG, Borowitz MJ, Kadota R, Cooper T, Shen V, Dahl G, Thottassery JV, Jeha S, Maloney K, Paul JA, Barry E, Carroll WL, Gaynon PS
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Blood 118: 6043-9 (2011)
PM ID: 21967976
343: Droniou-Bonzom ME, Reignier T, Oldenburg JE, Cox AU, Exline CM, Rathbun JY, Cannon PM
Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.
J Virol 85: 13457-62 (2011)
PM ID: 21976641 PMC3233171 [Available on 06/01/12]
344: Lee HR, Choi WC, Lee S, Hwang J, Hwang E, Guchhait K, Haas J, Toth Z, Jeon YH, Oh TK, Kim MH, Jung JU
Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein.
Nat Struct Mol Biol 18: 1336-44 (2011)
PM ID: 22056774
345: Jiang XX, Nguyen Q, Chou Y, Wang T, Nandakumar V, Yates P, Jones L, Wang L, Won H, Lee HR, Jung JU, Müschen M, Huang XF, Chen SY
Control of B cell development by the histone H2A deubiquitinase MYSM1.
Immunity 35: 883-96 (2011)
PM ID: 22169041
346: Lee HR, Brulois K, Wong L, Jung JU
Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.
Front Microbiol 3: 44 (2012)
PM ID: 22403573 PMC3293256
347: Punj V, Matta H, Chaudhary PM
A Computational Profiling of Changes in Gene Expression and Transcription Factors Induced by vFLIP K13 in Primary Effusion Lymphoma.
PLoS One 7: e37498 (2012)
PM ID: 22624040 PMC3356309
348: Matta H, Gopalakrishnan R, Graham C, Tolani B, Khanna A, Yi H, Suo Y, Chaudhary PM
Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.
PLoS One 7: e36601 (2012)
PM ID: 22590573 PMC3348130
349: Arutyunyan A, Stoddart S, Yi SJ, Fei F, Lim M, Groffen P, Feldhahn N, Groffen J, Heisterkamp N
Expression of cassini, a murine gamma-satellite sequence conserved in evolution, is regulated in normal and malignant hematopoietic cells.
BMC Genomics 13: 418 (2012)
PM ID: 22916712 PMC3505476
350: Liu HM, Aizaki H, Machida K, Ou JH, Lai MM
Hepatitis C virus translation preferentially depends on active RNA replication.
PLoS One 7: e43600 (2012)
PM ID: 22937067 PMC3427374
351: Trindade A, Djokovic D, Gigante J, Badenes M, Pedrosa AR, Fernandes AC, Lopes-da-Costa L, Krasnoperov V, Liu R, Gill PS, Duarte A
Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis.
PLoS One 7: e29863 (2012)
PM ID: 22279550 PMC3261161
352: Yu M, Gong D, Lim M, Arutyunyan A, Groffen J, Heisterkamp N
Lack of bcr and abr promotes hypoxia-induced pulmonary hypertension in mice.
PLoS One 7: e49756 (2012)
PM ID: 23152932 PMC3495860
353: Lee SH, Toth Z, Wong LY, Brulois K, Nguyen J, Lee JY, Zandi E, Jung JU
Novel Phosphorylations of IKKγ/NEMO.
MBio 3: e00411-12 (2012)
PM ID: 23131831 PMC3487776
354: Wang L, Hong B, Jiang X, Jones L, Chen SY, Huang XF
A20 controls macrophage to elicit potent cytotoxic CD4(+) T cell response.
PLoS One 7: e48930 (2012)
PM ID: 23145026 PMC3492139
355: Hong B, Lee SH, Song XT, Jones L, Machida K, Huang XF, Chen SY
A super TLR agonist to improve efficacy of dendritic cell vaccine in induction of anti-HCV immunity.
PLoS One 7: e48614 (2012)
PM ID: 23144910 PMC3492467
356: Rochanda L, Del Zoppo GJ, Feinstein DI, Liebman HA
Approach to the treatment, characterization and diagnosis of an acquired auto-antibody directed against factors prothrombin, factor X and factor IX: a case report and review of the literature.
Haemophilia 18: 102-7 (2012)
PM ID: 21707870
357: Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K
A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.
Blood 119: 469-75 (2012)
PM ID: 22086417 PMC3257012 [Available on 01/12/13]
358: Ma H, Qazi S, Ozer Z, Gaynon P, Reaman GH, Uckun FM
CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
Br J Haematol 156: 89-98 (2012)
PM ID: 22017452
359: Kim Y, Kwon EK, Jeon JH, So I, Kim IG, Choi MS, Kim IS, Choi JK, Jung JU, Cho NH
Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein.
J Gen Virol 93: 330-40 (2012)
PM ID: 22012462
360: Moon HJ, Lee JS, Choi YK, Park JY, Talactac MR, Chowdhury MY, Poo H, Sung MH, Lee JH, Jung JU, Kim CJ
Induction of type I interferon by high-molecular poly-γ-glutamate protects B6.A2G-Mx1 mice against influenza A virus.
Antiviral Res : (2012)
PM ID: 22401806
361: Campbell M, Chang PC, Huerta S, Izumiya C, Davis R, Tepper CG, Kim KY, Shevchenko B, Wang DH, Jung JU, Luciw PA, Kung HJ, Izumiya Y
Protein Arginine Methyltransferase 1-directed Methylation of Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen.
J Biol Chem 287: 5806-18 (2012)
PM ID: 22179613 PMC3285351 [Available on 02/17/13]
362: Liang C
Viral FLIPping autophagy for longevity.
Cell Host Microbe 11: 101-3 (2012)
PM ID: 22341458
363: Chaudhry P, Yang X, Wagner M, Jong A, Wu L
Retinoid-regulated FGF8f secretion by osteoblasts bypasses retinoid stimuli to mediate granulocytic differentiation of myeloid leukemia cells.
Mol Cancer Ther 11: 267-76 (2012)
PM ID: 22135230 PMC3277667 [Available on 02/01/13] NIHMS341307 [Available on 02/01/13]
364: Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM
Inherited genetic variation and overall survival following follicular lymphoma.
Am J Hematol : (2012)
PM ID: 22473939
365: Yang CS, Lee JS, Rodgers M, Min CK, Lee JY, Kim HJ, Lee KH, Kim CJ, Oh B, Zandi E, Yue Z, Kramnik I, Liang C, Jung JU
Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation.
Cell Host Microbe 11: 264-76 (2012)
PM ID: 22423966
366: Yang CS, Rodgers M, Min CK, Lee JS, Kingeter L, Lee JY, Jong A, Kramnik I, Lin X, Jung JU
The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity.
Cell Host Microbe 11: 277-89 (2012)
PM ID: 22423967
367: Piatek C, O'Connell CL, Liebman HA
Treating venous thromboembolism in patients with cancer.
Expert Rev Hematol 5: 201-9 (2012)
PM ID: 22475288
368: Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, Conter V, Otten J, Ohara A, Versluys AB, Escherich G, Heyman M, Silverman LB, Horibe K, Mann G, Camitta BM, Harbott J, Riehm H, Richards S, Devidas M, Zimmermann M
Outcomes after induction failure in childhood acute lymphoblastic leukemia.
N Engl J Med 366: 1371-81 (2012)
PM ID: 22494120 PMC3374496 NIHMS371844
369: Antony R, Sheng X, Ehsanipour EA, Ng E, Pramanik R, Klemm L, Ichihara B, Mittelman SD
Vitamin D protects acute lymphoblastic leukemia cells from dexamethasone.
Leuk Res 36: 591-3 (2012)
PM ID: 22341429 PMC3312954 [Available on 05/01/13] NIHMS357943 [Available on 05/01/13]
370: Lopez LA, Yang SJ, Exline CM, Rengarajan S, Haworth KG, Cannon PM
Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
J Virol 86: 5467-80 (2012)
PM ID: 22398279 PMC3347301 [Available on 11/01/12]
371: Levine MN, Gu C, Liebman HA, Escalante CP, Solymoss S, Deitchman D, Ramirez L, Julian J
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer.
J Thromb Haemost 10: 807-14 (2012)
PM ID: 22409262
372: Sir D, Kuo CF, Tian Y, Liu HM, Huang EJ, Jung JU, Machida K, Ou JH
Replication of hepatitis C virus RNA on autophagosomal membranes.
J Biol Chem 287: 18036-43 (2012)
PM ID: 22496373 PMC3365724
373: Zhao Z, Oh S, Li D, Ni D, Pirooz SD, Lee JH, Yang S, Lee JY, Ghozalli I, Costanzo V, Stark JM, Liang C
A Dual Role for UVRAG in Maintaining Chromosomal Stability Independent of Autophagy.
Dev Cell 22: 1001-16 (2012)
PM ID: 22542840 PMC3356442 [Available on 05/15/13] NIHMS367824 [Available on 05/15/13]
374: Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
J Clin Oncol 30: 1663-9 (2012)
PM ID: 22412151 PMC3383113
375: Cerhan JR, Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman N, Hartge P, Dogan A, Wang SS
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
Leuk Lymphoma 53: 1105-12 (2012)
PM ID: 22066713
376: Fei F, Lim M, Schmidhuber S, Moll J, Groffen J, Heisterkamp N
Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib).
Mol Cancer 11: 42 (2012)
PM ID: 22721004
377: Gong D, Shi W, Yi SJ, Chen H, Groffen J, Heisterkamp N
TGFbeta signaling plays a critical role in promoting alternative macrophage activation.
BMC Immunol 13: 31 (2012)
PM ID: 22703233
378: Wheeler DC, Waller LA, Cozen W, Ward MH
Spatial-temporal analysis of non-Hodgkin lymphoma risk using multiple residential locations.
Spat Spatiotemporal Epidemiol 3: 163-71 (2012)
PM ID: 22682442 PMC3372929 NIHMS372233
379: Ailawadhi S, Miecznikowski J, Gaile DP, Wang D, Sher T, Mulligan G, Bryant B, Wilding GE, Mashtare T, Stein L, Masood A, Neuwirth R, Lee KP, Chanan-Khan A
Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma.
Leuk Lymphoma 53: 1174-82 (2012)
PM ID: 22054286
380: Ailawadhi S, Aldoss IT, Yang D, Razavi P, Cozen W, Sher T, Chanan-Khan A
Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.
Br J Haematol 158: 91-8 (2012)
PM ID: 22533740
381: He M, Zhang W, Bakken T, Schutten M, Toth Z, Jung JU, Gill P, Cannon M, Gao SJ
Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.
Cancer Res 72: 3582-92 (2012)
PM ID: 22593192
382: Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J, Bostrom BC, Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Blood 120: 285-90 (2012)
PM ID: 22653976
383: Zonder JA, Mohrbacher AF, Singhal S, van Rhee F, Bensinger WI, Ding H, Fry J, Afar DE, Singhal AK
A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma.
Blood 120: 552-9 (2012)
PM ID: 22184404
384: Hong B, Peng G, Berry L, Gottschalk S, Jung JU, Chen SY, Huang XF
Generating CTLs against the subdominant EBV LMP antigens by transient expression of an A20 inhibitor with EBV LMP proteins in human DCs.
Gene Ther 19: 818-27 (2012)
PM ID: 22052242 PMC3288357 NIHMS324802
385: Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I, Australian National Endometrial Cancer Study Group
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.
Am J Epidemiol 176: 269-78 (2012)
PM ID: 22831825
386: Chitta KS, Paulus A, Ailawadhi S, Foster BA, Moser MT, Starostik P, Masood A, Sher T, Miller KC, Iancu DM, Conroy J, Nowak NJ, Sait SN, Personett DA, Coleman M, Furman RR, Martin P, Ansell SM, Lee K, Chanan-Khan AA
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.
Leuk Lymphoma : (2012)
PM ID: 22812491
387: Feldhahn N, Arutyunyan A, Stoddart S, Zhang B, Schmidhuber S, Yi SJ, Kim YM, Groffen J, Heisterkamp N
Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia.
Oncoimmunology 1: 618-629 (2012)
PM ID: 22934254
388: Parameswaran R, Yu M, Lyu MA, Lim M, Rosenblum MG, Groffen J, Heisterkamp N
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
Leukemia 26: 1786-96 (2012)
PM ID: 22373785 PMC3376225 NIHMS358801
389: Schroyens W, O'Connell C, Sykes DB
Complete and partial responses of the TEMPI syndrome to bortezomib.
N Engl J Med 367: 778-80 (2012)
PM ID: 22913703
390: Tarleton HP, Park SL, Zhu WM, Lee YC, Hashibe M, Morgenstern H, Tashkin DP, Mao JT, Cozen W, Mack TM, Zhang ZF
Body mass index change in adulthood and lung and upper aerodigestive tract cancers.
Int J Cancer 131: 1407-16 (2012)
PM ID: 22131048 PMC3402653 NIHMS341960
391: Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, Mackman N, Green R, Liebman HA
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation.
Thromb Res 130: 361-8 (2012)
PM ID: 22542362
392: Toth Z, Brulois KF, Wong LY, Lee HR, Chung B, Jung JU
Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
J Virol 86: 9696-707 (2012)
PM ID: 22740393 PMC3446579
393: Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU
Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.
J Virol 86: 9708-20 (2012)
PM ID: 22740391 PMC3446615
394: Piatek C, O'Connell C
Unsuspected pulmonary embolism: impact on mortality among cancer patients.
Curr Opin Pulm Med 18: 406-9 (2012)
PM ID: 22759768
395: Lesser DJ, Bhatia R, Tran WH, Oliveira F, Ortega R, Keens TG, Mittelman SD, Khoo MC, Davidson Ward SL
Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males.
Pediatr Res 72: 293-8 (2012)
PM ID: 22669298 PMC3427473 NIHMS388546
396: Mattano LA, Devidas M, Nachman JB, Sather HN, Hunger SP, Steinherz PG, Gaynon PS, Seibel NL, Children's Oncology Group
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
Lancet Oncol 13: 906-15 (2012)
PM ID: 22901620 PMC3448283 NIHMS403961
397: Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, Lacroute P, Leng J, Lian J, Monahan H, O'Geen H, Ouyang Z, Partridge EC, Patacsil D, Pauli F, Raha D, Ramirez L, Reddy TE, Reed B, Shi M, Slifer T, Wang J, Wu L, Yang X, Yip KY, Zilberman-Schapira G, Batzoglou S, Sidow A, Farnham PJ, Myers RM, Weissman SM, Snyder M
Architecture of the human regulatory network derived from ENCODE data.
Nature 489: 91-100 (2012)
PM ID: 22955619
398: Gargano JW, Wilkinson EJ, Unger ER, Steinau M, Watson M, Huang Y, Copeland G, Cozen W, Goodman MT, Hopenhayn C, Lynch CF, Hernandez BY, Peters ES, Saber MS, Lyu CW, Sands LA, Saraiya M
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction.
J Low Genit Tract Dis 16: 471-9 (2012)
PM ID: 22652576
399: Park AR, Oh D, Lim SH, Choi J, Moon J, Yu DY, Park SG, Heisterkamp N, Kim E, Myung PK, Lee JR
Regulation of dendritic arborization by BCR Rac1 GTPase-activating protein, a substrate of PTPRT.
J Cell Sci 125: 4518-31 (2012)
PM ID: 22767509
400: Gaynon PS, Harned TM, Therapeutic Advances in Childhood Leukemia/Lymphoma Consortium
ABT-751 in relapsed childhood acute lymphoblastic leukemia.
J Pediatr Hematol Oncol 34: 583-4 (2012)
PM ID: 22584778
401: Greisman HA, Lu Z, Tsai AG, Greiner TC, Yi HS, Lieber MR
IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.
Blood 120: 2864-7 (2012)
PM ID: 22915650 PMC3466967
402: Ying M, Liu G, Shimada H, Ding W, May WA, He Q, Adams GB, Wu L
Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.
Oncogene : (2012)
PM ID: 23045288
403: Gowin K, Thapaliya P, Samuelson J, Harrison C, Radia D, Andreasson B, Mascarenhas J, Rambaldi A, Barbui T, Rea CJ, Camoriano J, Gentry A, Kiladjian JJ, O'Connell C, Mesa R
Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients.
Haematologica 97: 1570-3 (2012)
PM ID: 22419578 PMC3487558
404: Acree SC, Tovar JP, Pattengale PK, Wang LL, Church JA, Gaynon PS, Cassarino DS
Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant.
Fetal Pediatr Pathol : (2012)
PM ID: 23092204
405: Hwang AE, Hamilton AS, Cockburn MG, Ambinder R, Zadnick J, Brown EE, Mack TM, Cozen W
Evidence of genetic susceptibility to infectious mononucleosis: a twin study.
Epidemiol Infect 140: 2089-95 (2012)
PM ID: 22152594
406: Becker N, Falster MO, Vajdic CM, de Sanjose S, Martínez-Maza O, Bracci PM, Melbye M, Smedby KE, Engels EA, Turner J, Vineis P, Costantini AS, Holly EA, Spinelli JJ, La Vecchia C, Zheng T, Chiu BC, Montella M, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Cozen W, Grulich AE, Newton R
Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
Int J Cancer 131: 2342-8 (2012)
PM ID: 22266776 PMC3406230 NIHMS352141
407: Aguilar B, Choi I, Choi D, Chung HK, Lee S, Yoo J, Lee YS, Maeng YS, Lee HN, Park E, Kim KE, Kim NY, Baik JM, Jung JU, Koh CJ, Hong YK
Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.
Cancer Res 72: 5833-42 (2012)
PM ID: 22942256 PMC3500425 NIHMS404933
408: Nieters A, Conde L, Slager SL, Brooks-Wilson A, Morton L, Skibola DR, Novak AJ, Riby J, Ansell SM, Halperin E, Shanafelt TD, Agana L, Wang AH, De Roos AJ, Severson RK, Cozen W, Spinelli J, Butterbach K, Becker N, de Sanjose S, Benavente Y, Cocco P, Staines A, Maynadié M, Foretova L, Boffetta P, Brennan P, Lan Q, Zhang Y, Zheng T, Purdue M, Armstrong B, Kricker A, Vajdic CM, Grulich A, Smith MT, Bracci PM, Chanock SJ, Hartge P, Cerhan JR, Wang SS, Rothman N, Skibola CF
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
Blood 120: 4645-8 (2012)
PM ID: 23047821 PMC3512239
409: Adams GB
Stem cells need their T.
Blood 120: 4279-80 (2012)
PM ID: 23175660
410: Liu Z, Tian Y, Machida K, Lai MM, Luo G, Foung SK, Ou JH
Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.
J Biol Chem 287: 41922-30 (2012)
PM ID: 23095753 PMC3516739
411: Khorana AA, O'Connell C, Agnelli G, Liebman HA, Lee AY, Subcommittee on Hemostasis and Malignancy of the SSC of the ISTH
Incidental venous thromboembolism in oncology patients.
J Thromb Haemost 10: 2602-4 (2012)
PM ID: 23362525 PMC3561673 NIHMS413524
412: Parekh C, Crooks GM
Critical Differences in Hematopoiesis and Lymphoid Development between Humans and Mice.
J Clin Immunol : (2012)
PM ID: 23274800
413: Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).
Br J Haematol : (2012)
PM ID: 23240761
414: Droniou-Bonzom ME, Cannon PM
A systems biology starter kit for arenaviruses.
Viruses 4: 3625-46 (2012)
PM ID: 23342371 PMC3528283
415: Orgel E, Mittelman SD
The Links Between Insulin Resistance, Diabetes, and Cancer.
Curr Diab Rep : (2012)
PM ID: 23271574